glp-1 long-term risks INFOGRAPHIC: The Hidden of Weight Loss Medications Your guide to GLP-1 side

Moreover, emerging therapeutic agents are under investigation

GLP-1R agonists are known to have beneficial effects in this large and steadily growing patient population, primarily through their effects on weight loss and insulin secretion, although emerging evidence suggests direct hepatic effects as well [152, 153]

We have also shown that they prevent the build-up of proteins associated with Alzheimers disease (at least in animal models), but the effect appears to be protective against future disease, rather than active disease. Key takeaways All of this points towards these drugs being protective for a number of diseases, many of which are driven by inflammation, says Dr Cork

One such agonist is L3740

This tubuloglomerular feedback mechanism is crucial for preserving renal blood flow and preventing kidney injury